The primary manifestation of the antiphospholipid antibody syndrome (APS) is thrombosis, which forms the core of the classification criteria for this syndrome. However, multiple other noncriteria ...
Antiphospholipid syndrome (APS) is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as ...
While antibodies normally help fight off infections, "autoantibodies" contribute to autoimmune diseases by recognizing and attacking a person's own body. Patients with autoimmune diseases have long ...
The presence of antiphospholipid antibodies is associated with an increased risk for future cardiovascular events, according to a new study. The findings point to possible new approaches to risk ...
A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.
“There are a lot of unanswered questions about how APS affects pediatric patients since evidence to date has been very limited,” said Jheel Pandya, MD, a pediatric rheumatology fellow at HSS and lead ...
Please provide your email address to receive an email when new articles are posted on . To examine the relationship between antiphospholipid antibodies and future atherosclerotic cardiovascular ...
Please provide your email address to receive an email when new articles are posted on . Most patients with chorea and antiphospholipid antibody were women, with chorea onset at an average age of 22.8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results